KORU Medical Systems Management
Management criteria checks 2/4
KORU Medical Systems' CEO is Linda Tharby, appointed in Apr 2021, has a tenure of 4.17 years. total yearly compensation is $1.27M, comprised of 44.7% salary and 55.3% bonuses, including company stock and options. directly owns 2.22% of the company’s shares, worth $2.76M. The average tenure of the management team and the board of directors is 3.2 years and 4.1 years respectively.
Key information
Linda Tharby
Chief executive officer
US$1.3m
Total compensation
| CEO salary percentage | 44.73% |
| CEO tenure | 4.2yrs |
| CEO ownership | 2.2% |
| Management average tenure | 3.2yrs |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
KORU Medical Systems, Inc. (NASDAQ:KRMD) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
May 08
KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Stock Retreats 27% But Revenues Haven't Escaped The Attention Of Investors
Mar 05KORU Medical Systems, Inc. (NASDAQ:KRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.10
Nov 16Impressive Turnaround At KORU Medical
Nov 06We're Interested To See How KORU Medical Systems (NASDAQ:KRMD) Uses Its Cash Hoard To Grow
Aug 29KORU Medical Systems, Inc. (NASDAQ:KRMD) Doing What It Can To Lift Shares
Jul 30Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues
Feb 15We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely
Sep 21Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower
Jul 14We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate
Sep 27Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans
Oct 27Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report
Aug 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2025 | n/a | n/a | -US$5m |
| Dec 31 2024 | US$1m | US$569k | -US$6m |
| Sep 30 2024 | n/a | n/a | -US$12m |
| Jun 30 2024 | n/a | n/a | -US$12m |
| Mar 31 2024 | n/a | n/a | -US$13m |
| Dec 31 2023 | US$977k | US$563k | -US$14m |
| Sep 30 2023 | n/a | n/a | -US$8m |
| Jun 30 2023 | n/a | n/a | -US$8m |
| Mar 31 2023 | n/a | n/a | -US$9m |
| Dec 31 2022 | US$1m | US$550k | -US$9m |
| Sep 30 2022 | n/a | n/a | -US$8m |
| Jun 30 2022 | n/a | n/a | -US$8m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | US$7m | US$398k | -US$5m |
Compensation vs Market: Linda's total compensation ($USD1.27M) is above average for companies of similar size in the US market ($USD646.03K).
Compensation vs Earnings: Linda's compensation has increased whilst the company is unprofitable.
CEO
Linda Tharby (57 yo)
Ms. Linda M. Tharby serves as President and Chief Executive Officer at KORU Medical Systems, Inc. (formerly known as Repro Med Systems, Inc.) since April 12, 2021 and serves as its Director since May 06, 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.2yrs | US$1.27m | 2.22% $ 2.8m | |
| CFO, Secretary & Treasurer | 2.9yrs | US$565.05k | 0.41% $ 513.9k | |
| Chief Operating Officer | 3.4yrs | no data | 0.16% $ 193.4k | |
| Interim Chief Commercial Officer | less than a year | no data | no data |
Experienced Management: KRMD's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.1yrs | US$1.27m | 2.22% $ 2.8m | |
| Director | 1.8yrs | US$110.00k | 0.073% $ 90.7k | |
| Independent Chairman of the Board | 6.1yrs | US$140.00k | 0.45% $ 555.0k | |
| Independent Director | 3.1yrs | US$125.00k | 0.17% $ 217.1k | |
| Lead Independent Director | 9.3yrs | US$120.50k | 1.12% $ 1.4m | |
| Independent Director | 4.1yrs | US$110.00k | 0.18% $ 225.2k | |
| Independent Director | 4.1yrs | US$110.00k | 0.18% $ 218.1k |
Experienced Board: KRMD's board of directors are considered experienced (4.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/02 10:19 |
| End of Day Share Price | 2025/06/02 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
KORU Medical Systems, Inc. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kyle Bauser | B. Riley Securities, Inc. |
| Anderson Schock | B. Riley Securities, Inc. |
| Caitlin Cronin | Canaccord Genuity |